Showing 191-200 of 5833 results for "".
DermWireTV: Skin Cancer Foundation’s Big See, Cosmetic Consumer Insights, Cosmetic Bootcamp Recap
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-skin-cancer-foundation-confronts-the-big-see-cosmetic-consumer-insights/19632/The Skin Cancer Foundation’s new multiyear public service campaign, “The Big See," urges proactive approaches to skin cancer diagnosis. Results of the Synchrony Financial Cosmetic Path to Purchase Research Study show that 8 in 10 cosmetic consumers said they researched a procedure or treatment befoUpdates from Principia, Sebacia, and Candela
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-updates-from-principia-sebacia-and-candela/19571/Phase 2 data for from the Believe-PV study for PRN1008 show that the investigational agent from Principia Biopharma reached the primary efficacy measure in pemphigus. Data confirm that Sebacia microparticles confer benefit in the management of acne vulgaris in real-world settings. Candela has rebranPopup Subscription Forms: Could They be Costing you Potential Patients?
https://practicaldermatology.com/topics/practice-management/popup/18364/If you are using popup subscription forms to build your email list, you could be losing potential patients while you gain subscribers. Watch this video from Ekwa.com to learn how to avoid common mistakes and build a strong mailing list the right way.How Effective is the Liquid Facelift?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/how-effective-is-the-liquid-facelift/18621/Liquid facelifts offer patients a non-surgical approach to creating the same effect as a surgery. Suneel Chilukuri, MD says by combing fillers, neuromodulators, devices, and at-home care, it's possible to tighten, lift, and generate new collagen. He says this non-invasive combination can achieve aboDrug Prices Soar, Amgen Files BLA for Biosimilar to Humira
https://practicaldermatology.com/topics/practice-management/dermwiretv-drug-prices-soar-amgen-files-bla-for-biosimilar-to-humira/18672/In this edition, Amgen Submits ABP 501—first Adalimumab biosimilar; prices for dermatology drugs jump and a survey explores patient knowledge of antibiotic resistance. Also, Almirall acquires Veltin from Sitefel/GSK.Skin Resurfacing, Pixel RF from Alma Lasers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/-skin-resurfacing-pixel-rf-from-alma-lasers/19241/Skin resurfacing with the innovative Pixel RF from Alma Lasers. Ready to fight the hands of time? Click here for more info: http://www.AlmaLasers.comVShape Facial Contouring by Alma Lasers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/vshape-facial-contouring-by-alma-lasers/19251/VShape is a non-invasive and pain-free treatment for facial contouring. Performed throughout the world using Alma Lasers Accent Ultra medical aesthetic technology. vShape: Bipolar RF TechnologyMaking Connections: Success in Your First Five Years
https://practicaldermatology.com/topics/practice-management/webinar-making-connections-success-in-your-first-five-years/19819/Experts share practical guidance to help dermatologists chart a course for success. Topics range from getting involved in clinical trials to finding opportunities for leadership. Learn how to gain confidence prescribing systemic agents, and explore opportunities in medical dermatology.FDA Approves New Drug for Prurigo Nodularis; Long-Term Use of Dupilumab Examined
https://practicaldermatology.com/series/dermwire-tv/fda-approves-new-drug-prurigo-nodularis-long-term-use-dupilumab-examined/26925/In this week's DermwireTV, the FDA approves Galderma's Nemluvio for adults with prurigo nodularis; a study examines the long-term use of dupilumab for atopic dermatitis; and Andrew Mastro discusses how to talk to patients about starting a Janus kinase (JAK) inhibitor for AD.FDA Approves Axillary Hyperhidrosis Treatment; Study Examines Biologic Outcomes in Psoriasis
https://practicaldermatology.com/series/dermwire-tv/fda-approves-axillary-hyperhidrosis-treatment-study-examines-biologic-outcomes-psoriasis/26562/In this week's DermwireTV, the FDA approves a first-of-its-kind gel for axillary hyperhidrosis; a new analysis examines how smoking, BMI, and age affect biologic outcomes in psoriasis; and the CEO of Aerolase joins us to discuss the latest trends in the aesthetic laser market.